Data Composite

Recall D-0551-2025

US Class II Ongoing · initiated 2025-07-22

Recalling firm

Hikma Pharmaceuticals USA Inc., NJ

Product

Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25

Reason for recall

Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

← All recalls